News

Research Seminars

Welcome to the Dept of Pharmaceutical Biosciences

Our department is part of the only Faculty of Pharmacy in Sweden.  We aim to provide an international and stimulating environment where researchers, teachers, postgraduate students, visiting researchers, students, technical and administrative staff can work together on issues relevant to future pharmaceutical drug development. Our education and research are conducted within several fields of modern life science. We offer many courses and programmes!

The Department is organised into a number of research groups working from the molecular level to population level and within several different disciplines. All research is undertaken with the overall aim of increasing the knowledge about pharmacokinetics and mechanisms of actions and adverse effects of pharmaceutical drugs. Teaching at the Department is conducted by professors, senior and junior lecturers as well as researchers and PhD students. The Department is centrally located within the large Uppsala University Biomedical Centre (BMC) and has around 110 employees as well as many scholarship holders and visiting researchers.

We are cooperating nationally and internationally with many universities and pharmaceutical drug companies in order to improve drug development and management as the basis for drug efficiency and safety.

For more information about our current research projects, click Research
For more information about our courses, click Education

Malin Andersson

Title: PhD
Position: Assistant professor at the Department of Pharmaceutical Biosciences

Read more

Ola Spjuth

Title: PhD
Position: Researcher at the Department of Pharmaceutical Biosciences, Uppsala University

Read more

Dissertations

  • Friday, May 25, 2012 13:15 B41, Biomedicinskt Centrum, Husargatan 3, Uppsala Petersson, Klas Population Pharmacodynamic Modeling and Methods for D2-receptor Antagonists [Free fulltext] [More information]

Publications

  • Ahmed, A., Li, J., Erlandsson-Harris, H., Stark, A., Bakalkin, G. et al. (2012). Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain, 153(1): 18-26 [DOI] [More information]
  • Andappan, M., Wu, X., Wallinder, C., Mahalingam, A., Wan, Y. et al. (2012). From the First Selective Non-Peptide AT(2) Receptor Agonist to Structurally Related Antagonists. Journal of Medicinal Chemistry, 55(5): 2265-2278 [DOI] [More information]
  • Andersson, H., Brittebo, E. (2012). Proangiogenic Effects of Environmentally Relevant Levels of Bisphenol A in Human Primary Endothelial Cells. Archives of Toxicology, 86(3): 465-474 [DOI] [More information]